WEREWOLF THERAPEUTICS, INC. Earnings Per Share (Basic)
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Earnings Per Share (Basic) of $0.08 per share for the 3-month period ending 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.08.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.28.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.17.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.36.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$1.05.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$1.86.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for fiscal 2021 was -$10.94.
- WEREWOLF THERAPEUTICS, INC. earnings per share, basic for fiscal 2020 was -$28.08.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.08 S-4 · filed 2026-09-22 | -$0.20 S-4 · filed 2026-09-22 | ||
| 2026-03-31 | -$0.28 10-Q · filed 2026-05-07 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-09-22 |
| 2025-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.32 S-4 · filed 2026-09-22 |
| 2025-09-30 | -$0.36 10-Q · filed 2025-11-04 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.16 10-Q · filed 2025-11-04 | -$1.62 derived: net income ÷ weighted average shares · filed 2026-09-22 |
| 2025-06-30 | -$0.40 S-4 · filed 2026-09-22 | -$0.80 S-4 · filed 2026-09-22 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-09-22 |
| 2025-03-31 | -$0.40 10-Q · filed 2026-05-07 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-09-22 |
| 2024-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-09-22 | -$1.63 S-4 · filed 2026-09-22 |
| 2024-09-30 | -$0.38 10-Q · filed 2025-11-04 | -$0.78 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$1.17 10-Q · filed 2025-11-04 | |
| 2024-06-30 | -$0.40 10-Q · filed 2025-08-14 | -$0.79 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$0.39 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$0.71 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$1.05 10-K · filed 2025-03-11 |
| 2023-09-30 | -$0.23 10-Q · filed 2024-11-07 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.72 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$0.14 10-Q · filed 2024-08-08 | -$0.49 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.34 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.79 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.86 10-K · filed 2024-03-07 |
| 2022-09-30 | -$0.40 10-Q · filed 2023-11-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.48 10-Q · filed 2023-11-14 | -$2.13 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-06-30 | -$0.53 10-Q · filed 2023-08-10 | -$1.09 10-Q · filed 2023-08-10 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$2.25 derived: net income ÷ weighted average shares · filed 2023-08-10 |
| 2022-03-31 | -$0.56 10-Q · filed 2023-05-11 | -$1.21 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.72 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$4.61 derived: net income ÷ weighted average shares · filed 2023-05-11 |
| 2021-12-31 | -$0.65 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.16 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$4.13 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$10.94 10-K · filed 2023-03-23 |
| 2021-09-30 | -$0.51 10-Q · filed 2022-11-10 | -$3.63 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$11.89 10-Q · filed 2022-11-10 | -$17.29 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$3.82 10-Q · filed 2022-08-11 | -$17.86 10-Q · filed 2022-08-11 | -$28.44 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$37.41 derived: net income ÷ weighted average shares · filed 2022-08-11 |
| 2021-03-31 | -$83.36 10-Q · filed 2022-05-10 | -$103.19 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$117.26 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$119.41 derived: net income ÷ weighted average shares · filed 2022-05-10 |
| 2020-12-31 | -$17.79 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$25.68 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$24.23 derived: net income ÷ weighted average shares · filed 2022-03-24 | -$28.08 10-K · filed 2022-03-24 |
| 2020-09-30 | -$6.61 10-Q · filed 2021-11-10 | -$4.12 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$8.03 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.35 10-Q · filed 2021-08-12 | -$1.80 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$4.58 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |